332 related articles for article (PubMed ID: 8078932)
41. Intertwining proteins in thymocyte development and cancer.
Murre C
Nat Immunol; 2000 Aug; 1(2):97-8. PubMed ID: 11248796
[No Abstract] [Full Text] [Related]
42. SCL assembles a multifactorial complex that determines glycophorin A expression.
Lahlil R; Lécuyer E; Herblot S; Hoang T
Mol Cell Biol; 2004 Feb; 24(4):1439-52. PubMed ID: 14749362
[TBL] [Abstract][Full Text] [Related]
43. Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia.
Patel B; Kang Y; Cui K; Litt M; Riberio MS; Deng C; Salz T; Casada S; Fu X; Qiu Y; Zhao K; Huang S
Leukemia; 2014 Feb; 28(2):349-61. PubMed ID: 23698277
[TBL] [Abstract][Full Text] [Related]
44. Deregulated expression of the TAL1 gene by t(1;5)(p32;31) in patient with T-cell acute lymphoblastic leukemia.
François S; Delabesse E; Baranger L; Dautel M; Foussard C; Boasson M; Blanchet O; Bernard O; Macintyre EA; Ifrah N
Genes Chromosomes Cancer; 1998 Sep; 23(1):36-43. PubMed ID: 9713995
[TBL] [Abstract][Full Text] [Related]
45. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein.
Huang S; Qiu Y; Stein RW; Brandt SJ
Oncogene; 1999 Sep; 18(35):4958-67. PubMed ID: 10490830
[TBL] [Abstract][Full Text] [Related]
46. Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues.
Cheng JT; Hsu HL; Hwang LY; Baer R
Oncogene; 1993 Mar; 8(3):677-83. PubMed ID: 8437851
[TBL] [Abstract][Full Text] [Related]
47. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation.
Visvader JE; Mao X; Fujiwara Y; Hahm K; Orkin SH
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13707-12. PubMed ID: 9391090
[TBL] [Abstract][Full Text] [Related]
48. Functional diversity of LIM proteins: amino-terminal activation domains in the oncogenic proteins RBTN1 and RBTN2.
Sánchez-García I; Axelson H; Rabbitts TH
Oncogene; 1995 Apr; 10(7):1301-6. PubMed ID: 7731680
[TBL] [Abstract][Full Text] [Related]
49. Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
Ferrando AA; Herblot S; Palomero T; Hansen M; Hoang T; Fox EA; Look AT
Blood; 2004 Mar; 103(5):1909-11. PubMed ID: 14604958
[TBL] [Abstract][Full Text] [Related]
50. E-box sequence and context-dependent TAL1/SCL modulation of basic helix-loop-helix protein-mediated transcriptional activation.
Nielsen AL; Norby PL; Pedersen FS; Jorgensen P
J Biol Chem; 1996 Dec; 271(49):31463-9. PubMed ID: 8940159
[TBL] [Abstract][Full Text] [Related]
51. The hematopoietic regulator TAL1 is required for chromatin looping between the β-globin LCR and human γ-globin genes to activate transcription.
Yun WJ; Kim YW; Kang Y; Lee J; Dean A; Kim A
Nucleic Acids Res; 2014 Apr; 42(7):4283-93. PubMed ID: 24470145
[TBL] [Abstract][Full Text] [Related]
52. P/CAF-mediated acetylation regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL.
Huang S; Qiu Y; Shi Y; Xu Z; Brandt SJ
EMBO J; 2000 Dec; 19(24):6792-803. PubMed ID: 11118214
[TBL] [Abstract][Full Text] [Related]
53. FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2.
Fleskens V; Mokry M; van der Leun AM; Huppelschoten S; Pals CE; Peeters J; Coenen S; Cardoso BA; Barata JT; van Loosdregt J; Coffer PJ
Oncogene; 2016 Aug; 35(31):4141-8. PubMed ID: 26686090
[TBL] [Abstract][Full Text] [Related]
54. TAL1 expression does not occur in the majority of T-ALL blasts.
Delabesse E; Bernard M; Meyer V; Smit L; Pulford K; Cayuela JM; Ritz J; Bourquelot P; Strominger JL; Valensi F; Macintyre EA
Br J Haematol; 1998 Jul; 102(2):449-57. PubMed ID: 9695959
[TBL] [Abstract][Full Text] [Related]
55. Characterization of DNA-binding-dependent and -independent functions of SCL/TAL1 during human erythropoiesis.
Ravet E; Reynaud D; Titeux M; Izac B; Fichelson S; Roméo PH; Dubart-Kupperschmitt A; Pflumio F
Blood; 2004 May; 103(9):3326-35. PubMed ID: 14715640
[TBL] [Abstract][Full Text] [Related]
56. Sequence determinants of DNA binding by the hematopoietic helix-loop-helix transcription factor TAL1: importance of sequences flanking the E-box core.
Gould KA; Bresnick EH
Gene Expr; 1998; 7(2):87-101. PubMed ID: 9699481
[TBL] [Abstract][Full Text] [Related]
57. Simultaneous rearrangements of TAL1 and LMO2 in T-cell acute lymphoblastic leukemia.
Kim HK; Lim JH; Koh KN; Chi HS; Seo EJ
Int J Lab Hematol; 2014 Oct; 36(5):e69-70. PubMed ID: 24330618
[No Abstract] [Full Text] [Related]
58. T-cell acute lymphoblastic leukemia--the associated gene SCL/tal codes for a 42-Kd nuclear phosphoprotein.
Goldfarb AN; Goueli S; Mickelson D; Greenberg JM
Blood; 1992 Dec; 80(11):2858-66. PubMed ID: 1450410
[TBL] [Abstract][Full Text] [Related]
59. T-cell acute lymphoblastic leukemia and the associated basic helix-loop-helix gene SCL/tal.
Goldfarb AN; Greenberg JM
Leuk Lymphoma; 1994 Jan; 12(3-4):157-66. PubMed ID: 8167548
[TBL] [Abstract][Full Text] [Related]
60. Multiple functions of Ldb1 required for beta-globin activation during erythroid differentiation.
Song SH; Kim A; Ragoczy T; Bender MA; Groudine M; Dean A
Blood; 2010 Sep; 116(13):2356-64. PubMed ID: 20570862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]